A Wheaton, Ill., startup founded by an ophthalmologist is working on an artificial silicon retina that could restore sight to those suffering from macular degeneration-the leading cause of blindness in people older than 65. The device is a silicon wafer 3 millimeters across covered with photodiodes. With the wafer implanted in the retina, the photodiodes convert light into electrical impulses that travel through the optic nerve to the brain. The photodiodes will be packed so densely that the “resolution will theoretically be as good as normal vision,” says Optobionics founder Alan Chow; Stanford University’s Nanofabrication Center is collaborating on the miniaturization.
The implant has induced retinal activity in animals, but studies with human volunteers are more than a year away. Because the photodiodes are sensitive to infrared as well as visible light, Chow says these first subjects may report some odd sightings, such as beams shooting from a TV remote control.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
It will soon be easy for self-driving cars to hide in plain sight. We shouldn’t let them.
If they ever hit our roads for real, other drivers need to know exactly what they are.
This is the first image of the black hole at the center of our galaxy
The stunning image was made possible by linking eight existing radio observatories across the globe.
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.